Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250525007) titled 'Effectiveness of metformin prolonged-release on achievement of optimal glycemic control in gestational diabetes: A pilot, randomized, double-blind, clinical trial' on May 25.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Merck Ltd.
Condition:
Gestational diabetes
Diabetes, gestational
Metformin
Diabetes, gestational
Metformin
Intervention:
Metformin PR 750 mg oral daily. Dosage adjustment every 2 weeks until 6 weeks. The maximum dose is 2000 mg/day.,One tablet of placebo oral daily and increase to 2 tablets per day if glycemic control is inadequate. Dosage adjustment will be made eve...